Core Viewpoint - The introduction of the EVO+ICL (V5) implantable contact lens in Wuxi marks a significant advancement in myopia correction, particularly for patients with night vision issues, providing a more personalized and precise solution [1][3]. Group 1: Product Introduction - The EVO+ICL (V5) lens is recognized as an "optimized version for night vision" and has been successfully implanted in Wuxi, with the first surgery performed by Dr. Gu Yong [1]. - This new lens aims to enhance night vision quality and offers a solution for myopia patients who struggle with night-time visibility [1][3]. Group 2: Patient Experience - Ms. Lin, the first patient to receive the EVO+ICL (V5) lens, experienced significant improvement in her night vision, allowing her to resume activities like night running without the hindrance of glare and distortion [2]. - The surgery was completed in approximately ten minutes, and her vision improved to 1.0 shortly after the procedure [2]. Group 3: Key Upgrades - The EVO+ICL (V5) features two major upgrades: enhanced night vision quality through an optimized optical zone design, and improved precision in correcting myopia for patients with lower degrees of myopia [3]. - The lens design reduces night-time visual disturbances such as halos and glare, benefiting individuals who drive or work at night [3]. Group 4: Target Patient Demographics - The EVO+ICL (V5) is particularly suitable for five types of patients: those with high night vision requirements, larger dark pupils, myopia between 50-1400 degrees, thin corneas, and those seeking a non-corneal cutting correction method [5]. - The introduction of this lens provides a more personalized choice for patients, emphasizing the importance of individualized assessments prior to surgery [5]. Group 5: Technical Requirements - The EVO+ICL (V5) lens requires a higher level of surgical expertise due to its larger optical zone, necessitating precise evaluations of various ocular parameters by the surgeon [7]. - Wuxi Huaxia Eye Hospital, led by a specialized team, is committed to offering high-quality, personalized eye care services, including the new EVO+ICL (V5) lens [7].

▲3D导航显微镜下EVO+ ICL (V5) 晶体植入术 术中革命：3D导航实现"手术实时透视" 传统ICL手术中，晶体的大小、拱高、位置是否合适，往往需要术后通过检查才能确认。一旦出现偏 差，患者可能面临二次调整。而此次手术中，南京爱尔眼科医院首次将3D导航系统与V5晶体植入术结 合。 2026年1月4日，南京爱尔眼科医院屈光手术科成功完成全国首批、江苏省首例EVO+ ICL (V5) 晶体植入 手术。此次手术由瑞士STAAR ICL国际认证专家、南京爱尔眼科医院屈光手术科主任熊娟主刀。术中 全程搭载蔡司ARTEVO 800数字导航3D显微镜，实现了晶体植入过程的实时可视化与数据动态监测，将 ICL手术精准度从"术后验证"提升至"术中把关"。 技术迭代：V5晶体成夜间视觉"守护者" 对于很多近视人群来说，夜晚并非宁静的时刻。夜间开车常被对向车辆的远光灯晃得眼前一片光晕，下 班路上霓虹灯光散成一片星芒，甚至夜间散步也因视物模糊而小心翼翼——这些长期困扰近视人群 的"夜视力痛点"，如今有了更精准的解决方案。 "很多患者，尤其是暗瞳较大的人群，在传统屈光手术后夜间视觉质量会打折扣。"熊娟主任解释道，此 次植入的E ...